03309 C-MER MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.43X | Oper Margin | 9.3% |
|---|---|---|---|
| LT Debt/Equity | 14.4% | Net Margin | 5.2% |
| Total Debt/Equity | 23.6% | Return on Equity | 5.7% |
| Price/Book | 0.90X | Return on Assets | 3.7% |
| (HKD 1.310) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 100.37 | -135.16 | 62.00 | -21.88 | 21.86 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +174.3 | -318.0 | +383.4 | -200.1 | +450.0 |
| Earnings Per Share (HKD) | 0.083 | -0.11 | 0.049 | -0.018 | 0.019 |
| Earnings Per Share Growth (%) | +176.0 | -321.9 | +379.1 | -193.2 | +433.3 |
| Dividend Per Share (HKD) | 0.030 | 0.020 | No dividend | No dividend | No dividend |
| P/E* (X) | 15.73 | N/A | 26.52 | N/A | 68.95 |
| Yield (%) | 2.29 | 1.53 | N/A | N/A | N/A |
| Dividend Share (%) | 36.01 | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 1.464 | 1.396 | 1.470 | 1.473 | 1.157 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (HKDMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,947 | 1,913 | +1.8 | 1,924 |
| Operating Result | 130.628 | -73.817 | -277.0 | 121.226 |
| Associates | -0.581 | -0.975 | -40.4 | 3.164 |
| Profit Before Taxation | 155.52 | -76.221 | -304.0 | 124.269 |
| Taxation | 44.346 | 32.093 | +38.2 | 37.934 |
| Profit /( Loss) After Taxation | 111.174 | -108.314 | -202.6 | 86.335 |
| Minority Interests | 10.808 | 26.849 | -59.7 | 24.337 |
| Net Profit | 100.366 | -135.163 | -174.3 | 61.998 |
| Earnings Per Share () | 0.0833 | -0.1096 | -176.0 | 0.0494 |
| Dividend Per Share () | 0.0300 | 0.0200 | +50.0 | 0.0000 |
| Announcement Date | 2026-03-27 | 2025-03-21 | NA | 2024-03-26 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
